DaVita Venture Group funds and builds health tech ventures to improve kidney disease patient care. As part of DaVita Inc., it invests in, develops, and launches products and businesses across digital health, pharmaceuticals and medical devices, and care delivery models. Core areas use digital health, data and connectivity to improve care delivery and reduce costs. It targets companies offering digitally enabled products and services that expand access to care, including home treatments and value-based care models. The group seeks to scale patient-centric care globally by partnering with health care innovators.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Mahesh KrishnanGroup Vice President, DaVita Venture Group
- Nick RolfesSenior Director, Venture Capital
- Will TonelliManager, Venture Capital
- Brad MarzulloVice President, Corporate Development, Venture Capital, and Partnerships
Notable investments
Egenesis, Greater Good Health, Wellth, Dock Health, Vynca, Xeltis, Pathalys, R1 Therapeutics, Miromatrix, Samesky Health